Literature DB >> 15185046

Vasodilatory shock after surgery for aortic valve endocarditis: use of low-dose vasopressin.

E Lechner1, H A Dickerson, C D Fraser, A C Chang.   

Abstract

This is the case report of a 13-year-old male who developed vasopressor-resistant hypotension after cardiac surgery for endocarditis. As norepinephrine resulted in aggravation of the preexisting ventricular arrhythmia, vasopressin was used to maintain blood pressure. The vasopressin continuous infusion was started at 0.00002 units/kg/min and titrated up to 0.0003 U/kg/min. This low dose led to resolution of hypotension without causing side effects. As the appropriate indication and dose of vasopressin is not established, the cautious use of vasopressin in children is recommended.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15185046     DOI: 10.1007/s00246-003-0544-x

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  11 in total

1.  Arginine vasopressin in the treatment of 50 patients with postcardiotomy vasodilatory shock.

Authors:  D L Morales; D Gregg; D N Helman; M R Williams; Y Naka; D W Landry; M C Oz
Journal:  Ann Thorac Surg       Date:  2000-01       Impact factor: 4.330

2.  Unique features of infective endocarditis in childhood.

Authors:  Patricia Ferrieri; Michael H Gewitz; Michael A Gerber; Jane W Newburger; Adnan S Dajani; Stanford T Shulman; Walter Wilson; Ann F Bolger; Arnold Bayer; Matthew E Levison; Thomas J Pallasch; Tommy W Gage; Kathryn A Taubert
Journal:  Pediatrics       Date:  2002-05       Impact factor: 7.124

3.  Pro: Vasopressin is the vasoconstrictor of choice after cardiopulmonary bypass.

Authors:  John V Booth; David Schinderle; Ian J Welsby
Journal:  J Cardiothorac Vasc Anesth       Date:  2002-12       Impact factor: 2.628

4.  What about vasopressin?

Authors:  D W Ryan; A J Kilner
Journal:  Intensive Care Med       Date:  2002-06       Impact factor: 17.440

Review 5.  Physiology of vasopressin relevant to management of septic shock.

Authors:  C L Holmes; B M Patel; J A Russell; K R Walley
Journal:  Chest       Date:  2001-09       Impact factor: 9.410

6.  Intravenous arginine-vasopressin in children with vasodilatory shock after cardiac surgery.

Authors:  E B Rosenzweig; T J Starc; J M Chen; S Cullinane; D M Timchak; W M Gersony; D W Landry; M E Galantowicz
Journal:  Circulation       Date:  1999-11-09       Impact factor: 29.690

7.  Beneficial effects of short-term vasopressin infusion during severe septic shock.

Authors:  Bhavesh M Patel; Dean R Chittock; James A Russell; Keith R Walley
Journal:  Anesthesiology       Date:  2002-03       Impact factor: 7.892

8.  Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent.

Authors:  M Argenziano; J M Chen; A F Choudhri; S Cullinane; E Garfein; A D Weinberg; C R Smith; E A Rose; D W Landry; M C Oz
Journal:  J Thorac Cardiovasc Surg       Date:  1998-12       Impact factor: 5.209

9.  Intravenous vasopressin and gastrointestinal hemorrhage in children.

Authors:  D W Tuggle; K G Bennett; J Scott; W P Tunell
Journal:  J Pediatr Surg       Date:  1988-07       Impact factor: 2.545

10.  Use of vasopressin in refractory hypotension in children with vasodilatory shock: five cases and a review of the literature.

Authors:  Jennifer L Liedel; William Meadow; James Nachman; Tracy Koogler; Madelyn D Kahana
Journal:  Pediatr Crit Care Med       Date:  2002-01       Impact factor: 3.624

View more
  3 in total

Review 1.  The role of vasopressin and terlipressin in catecholamine-resistant shock and cardio-circulatory arrest in children: review of the literature.

Authors:  Sascha Meyer; William McGuire; Sven Gottschling; Ghiath Mohammed Shamdeen; Ludwig Gortner
Journal:  Wien Med Wochenschr       Date:  2011-01-25

2.  Clinical impact of vasopressin infusion on hemodynamics, liver and renal function in pediatric patients.

Authors:  Nameet Jerath; Helena Frndova; Brian W McCrindle; Rebecca Gurofsky; Tilman Humpl
Journal:  Intensive Care Med       Date:  2008-03-19       Impact factor: 17.440

Review 3.  Inotropes for Preterm Infants: 50 Years on Are We Any Wiser?

Authors:  Aisling A Garvey; Elisabeth M W Kooi; Eugene M Dempsey
Journal:  Front Pediatr       Date:  2018-04-06       Impact factor: 3.418

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.